COMMUNIQUÉS West-GlobeNewswire

-
Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference
07/02/2024 -
BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case
07/02/2024 -
FundaMental Pharma GmbH announces publication of a groundbreaking Proof-of-Concept Study in Cell Reports Medicine using a TwinF Interface Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis
07/02/2024 -
Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
07/02/2024 -
Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
07/02/2024 -
Renexxion Ireland’s European Partner, Dr. Falk Pharma GmbH, has Elected PPI-non-responsive Symptomatic GERD as the Second Naronapride Indication to Develop and Commercialize in their Licensed Territories
07/02/2024 -
Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™
07/02/2024 -
Recce Pharmaceuticals Establishes Strategic Partnership in South-East Asia to Accelerate Clinical Program
07/02/2024 -
Artios Pharma Strengthens Financial Leadership with Appointment of Christine Silverstein as Chief Financial Officer
07/02/2024 -
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
07/02/2024 -
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
07/02/2024 -
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy
07/02/2024 -
Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer
07/02/2024 -
Stryker declares a $0.80 per share quarterly dividend
07/02/2024 -
Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.
07/02/2024 -
Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
07/02/2024 -
Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome
07/02/2024 -
Theriva Biologics Announces Positive Recommendation from the Independent Data Monitoring Committee of VIRAGE, the Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
07/02/2024 -
Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method
07/02/2024
Pages